American Stock Exchange Lists the Common Stock of Rexahn Pharmaceuticals, Inc.
27 Mai 2008 - 5:11PM
PR Newswire (US)
NEW YORK, May 27 /PRNewswire/ -- The American Stock Exchange(R)
(Amex(R)) today listed the common stock of Rexahn Pharmaceuticals,
Inc. under the ticker symbol RNN. Rexahn Pharmaceuticals is a
biopharmaceutical company leveraging its proprietary technology
platform to discover, develop and commercialize innovative
treatments for cancer, central nervous system disorders, sexual
dysfunction and other unmet medical needs. Rexahn's compounds are
designed to uniquely treat various disease states while
significantly minimizing side effects in order to allow patients to
regain quality of life through therapy. "We are pleased to welcome
Rexahn Pharmaceuticals to the American Stock Exchange," said Neal
Wolkoff, Chairman and CEO, of the Amex. "We look forward to working
with Rexahn in building increased awareness and visibility within
the investment community." "As we continue to aggressively pursue
our clinical development efforts, our listing on the Amex will
increase shareholder value and provide expanded visibility to the
investment community and capital markets, at large," stated Dr.
Chang H. Ahn, Chairman and Chief Executive Officer of Rexahn. The
specialist for Rexahn Pharmaceuticals, Inc. is AGS Specialist
Partners. For further information on RNN and other Amex-listed
companies, please visit http://www.amex.com/. About American Stock
Exchange The American Stock Exchange(R) (Amex(R)) offers trading
across a full range of equities, options and exchange traded funds
(ETFs), including structured products and HOLDRS(SM). In addition
to its role as a national equities market, the Amex is the pioneer
of the ETF, responsible for bringing the first domestic product to
market in 1993. Leading the industry in ETF listings, the Amex
lists 401 ETFs to date. The Amex is also one of the largest options
exchanges in the U.S., trading options on broad-based and sector
indexes as well as domestic and foreign stocks. For more
information, please visit http://www.amex.com/. DATASOURCE:
American Stock Exchange CONTACT: Catherine Chantharaj of American
Stock Exchange, +1-212-306-1689, Web site: http://www.amex.com/
Copyright